Becton, Dickinson and Co. | BDX - Actif À Court Terme





Actif À Court Terme Changement Date
Abbott USD 25.51B 488M 2026-03
Agilent USD 4.76B 148M 2026-03
Align Technology USD 2.66B 38.87M 2026-03
AngioDynamics USD 161.35M 4.69M 2025-09
Avanos Medical USD 325M 30.4M 2026-03
Baxter International USD 6.85B 25M 2026-03
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Bio-Rad Laboratories USD 2.94B 35.9M 2026-03
Boston Scientific USD 8.68B 110M 2026-03
Cooper Companies USD 2.3B 166M 2026-03
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 1.85B 178M 2026-03
Dexcom USD 4.33B 298.4M 2026-03
Edwards Lifesciences USD 6.23B 510.2M 2026-03
Globus Medical USD 2.2B 72.51M 2026-03
Insulet USD 1.71B 204.5M 2026-03
Integra LifeSciences USD 1.17B 12.47M 2026-03
Intuitive Surgical USD 11.52B 881.5M 2026-03
J&J USD 59.17B 3.55B 2026-03
Medtronic USD 24.07B 75M 2025-12
Solventum Corp USD 3.58B 276M 2026-03
Stryker USD 13.34B 1.42B 2026-03
Tandem Diabetes Care USD 887.1M 268.96M 2026-03
Teleflex USD 1.86B 78.67M 2026-03
Terumo JPY 861.04B 45.48B 2026-03
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Zimmer Biomet Holdings USD 4.96B 157.4M 2026-03